Community Memorial Health System Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2020
NCT04488367
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Community Memorial Health System

Active Ingredients

Drugs in Phase 1 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 1)

Hip Fractures (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2